Skip to content

Coverage research for clinicians

The agent that does coverage research before you prescribe.

Manoa reads the policy documents, compares the options, works out the step therapy logic, and returns a ranked answer with citations. You make the prescribing call.

Solo $79/mo. 7-day free trial. No EHR integration required.

The problem

There's a chunk of every clinician's day that doesn't have a name.

You've seen the patient. You have a treatment in mind. The EHR shows some information about coverage, but you don't trust it. So you open a browser tab, find the payer's policy document, maybe read it, maybe call the payer. Eventually you pick something, write the prescription, and hope. That work doesn't have a name in the EHR. It doesn't have a name in the survey data either, which lumps it under "prior authorization" even though most of it happens before any PA paperwork exists. It's the work that makes the paperwork possible, and almost no software touches it.

13 hrs/wk

per clinician on insurance work

63%

of clinicians can't tell in advance whether a Rx needs PA

27%

say EHR coverage data is rarely or never accurate

AMA 2025 Prior Authorization Physician Survey (n=1,000, collected December 2025).

How it works

Three steps. Three minutes. No setup.

  1. 1

    Describe

    Tell Manoa about the patient.

    Type the case the way you'd describe it to a colleague. Condition, plan, anything else you know. Partial inputs are fine; Manoa asks follow-up questions to fill in what matters.

  2. 2

    Compare

    See every realistic option.

    Manoa returns a ranked comparison across coverage, cost, step therapy, and speed. Drill into any option to see why it's covered, what's required, and the cash-pay path.

  3. 3

    Decide

    Walk into the room with real options.

    Pick the right path with full visibility into what's actually accessible for this patient. No more best guesses. No more pajama-time research.

The product

One question. Every realistic option. Ranked.

Manoa runs in a browser tab next to your EHR. Describe a patient the way you'd describe them to a colleague. Manoa returns a side-by-side comparison of treatment options for this specific patient and this specific plan, with coverage likelihood, step therapy requirements, estimated cost, speed to approval, and a cash-pay alternative for every option. Whether you know what to prescribe, you're working it out, or insurance has shut the door, same product, same flow.

Tier 1 · Strong

Dupixent

dupilumab · 300 mg SC q2w

Likely covered
Step therapy
3 of 3 met
Est. cost
$0–35 / mo
Approval
~2 weeks

Tier 2 · Worth considering

Nucala

mepolizumab · 100 mg SC q4w

Possibly covered
Step therapy
2 of 3 met
Est. cost
$50–120 / mo
Approval
3–4 weeks

Tier 3 · Long shot

Ohtuvayre

ensifentrine · 3 mg INH BID

Unlikely
Step therapy
Not satisfied
Est. cost
Appeal-dependent
Approval
6+ weeks

Illustrative example. 62-year-old patient with severe eosinophilic COPD on Aetna Commercial PPO (CA). Real coverage depends on the live plan policy.

From our design partners

Clinicians on the gap, in their words.

“They won't cover that? Well what will they cover? This is where you waste the most amount of time. I don't have x-ray vision to know what can be covered instead.”
Manoa design partner, April 2026
“It's like navigating an information jungle to answer what is covered for this patient, this product, this insurance, this condition, and this time.”
Medical director, Manoa design partner
“This is exactly what we need.”
Primary care clinician, after the Manoa prototype demo

Pro tier, coming Q3

If you use a scribe, every prescription gets coverage-checked before you sign off.

The scribe drafts the note. Manoa coverage-checks every prescription in the background. By the time you review the note, the coverage analysis is already there, with primary and alternative options ranked for the patient's plan.

Works on top of your existing scribe (Freed first, others added as our users adopt them). No new workflow to learn.

Scribed note

HPI: 62yo with severe eosinophilic COPD, persistent dyspnea on albuterol + ICS-LABA, eos 380.

A&P: Severe COPD with eosinophilic phenotype. Add-on biologic.

Plan: Trelegy Ellipta 100/62.5/25 mcg INH BID.

Manoa coverage analysis

Trelegy Ellipta

fluticasone/umeclidinium/vilanterol, 100/62.5/25 mcg INH BID

Likely covered
Step therapy
3 of 3 met
Est. cost
$0 to $35 / mo

2 ranked alternatives also prepared (Dupixent, Nucala).

and we'll prioritize you for V1.5 access.

Pricing

Priced for clinicians, not procurement.

Solo

$79 per month
  • Chat agent for coverage research
  • Unlimited cases
  • Citations on every answer
  • Web app
  • 7-day free trial

Pro

Coming Q3
$119 per month
  • Everything in Solo
  • Async coverage analysis on every prescription in your scribed notes
  • Browser extension for EHR context auto-fill
  • 7-day free trial

Practice

Coming Q4
$179 per seat, per month, 3-seat minimum
  • Everything in Pro
  • Shared research workspace for clinician and MA
  • Voice agent for benefit verification
  • SMART on FHIR (bidirectional EHR read/write)
  • Panel-level coverage analysis
  • Practice analytics dashboard
  • Audit and compliance log
  • Priority payer ingestion (30-day SLA)

On the AMA 13-hour anchor, Pro is roughly 4% of total PA burden. About 24x ROI in year one. Heavier-PA specialties (rheumatology, GI, derm, oncology, psychiatry) scale higher.

Request access on the web app.

Manoa rolls out by hand to clinicians at small and mid-sized practices. Add your email and we'll send you a sign-up link as soon as we have a seat for you.

We don't sell or share your information. Manoa is designed for queries without PHI: no patient names, MRNs, or other identifiers. Unsubscribe at any time.